Related Experiment Videos
[Synchronous bilateral breast cancers].
Voprosy Onkologii
|January 1, 1986
Summary
Mammography can detect synchronous contralateral breast cancer 3 years earlier than clinical exams. Many metachronous cancers are actually overlooked synchronous cases, highlighting the need for comprehensive screening.
Area of Science:
- Oncology
- Radiology
- Pathology
Context:
- Mammography and aiming biopsy are key diagnostic tools in breast cancer detection.
- Synchronous contralateral breast cancer occurs in approximately 2.4% of cases.
- Early detection of contralateral breast cancer significantly impacts treatment strategies.
Purpose:
- To evaluate the efficacy of mammography in detecting synchronous contralateral breast cancer.
- To compare the detection timeline of mammography versus clinical examination.
- To re-evaluate the classification of metachronous breast cancers as potentially synchronous.
Summary:
- Mammography allows for the detection of synchronous contralateral breast cancer an average of 3 years earlier than clinical examination alone.
- Increased proliferation in contralateral breast tissue is not a definitive indicator due to age-related decreases in proliferation rates.
- A significant proportion of metachronous breast cancers may represent initially undetected synchronous tumors.
Impact:
- Improved early detection rates for contralateral breast cancer through mammography.
- Potential reclassification of metachronous cancers, influencing treatment protocols.
- Enhanced understanding of breast cancer development and detection nuances.